Safety and Tolerability of Essential Oil from Cinnamomum zeylanicum Blume Leaves with Action on Oral Candidosis and Its Effect on the Physical Properties of the Acrylic Resin.

Autor: Oliveira Jde A; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil., da Silva IC; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil., Trindade LA; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil., Lima EO; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil., Carlo HL; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil., Cavalcanti AL; Post-Graduate Program in Dentistry, State University of Paraíba, Campina Grande, PB, Brazil., de Castro RD; Post-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil ; Post-Graduate Program in Dentistry, State University of Paraíba, Campina Grande, PB, Brazil.
Jazyk: angličtina
Zdroj: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2014; Vol. 2014, pp. 325670. Date of Electronic Publication: 2014 Dec 09.
DOI: 10.1155/2014/325670
Abstrakt: The anti-Candida activity of essential oil from Cinnamomum zeylanicum Blume, as well as its effect on the roughness and hardness of the acrylic resin used in dental prostheses, was assessed. The safety and tolerability of the test product were assessed through a phase I clinical trial involving users of removable dentures. Minimum inhibitory concentration (MIC) and minimum fungicidal concentrations (MFC) were determined against twelve Candida strains. Acrylic resin specimens were exposed to artificial saliva (GI), C. zeylanicum (GII), and nystatin (GIII) for 15 days. Data were submitted to ANOVA and Tukey posttest (α = 5%). For the phase I clinical trial, 15 healthy patients used solution of C. zeylanicum at MIC (15 days, 3 times a day) and were submitted to clinical and mycological examinations. C. zeylanicum showed anti-Candida activity, with MIC = 625.0 µg/mL being equivalent to MFC. Nystatin caused greater increase in roughness and decreased the hardness of the material (P < 0.0001), with no significant differences between GI and GII. As regards the clinical trial, no adverse clinical signs were observed after intervention. The substance tested had a satisfactory level of safety and tolerability, supporting new advances involving the clinical use of essential oil from C. zeylanicum.
Databáze: MEDLINE